Nadkarni Anita H, Singh Aradhana A, Colaco Stacy, Hariharan Priya, Colah Roshan B, Ghosh Kanjaksha
Department of Haematogenetics, National Institute of Immunohaematology (ICMR), Mumbai, India.
Surat Raktadan Kendra and Research Center, Udhana - Magdalla Road, Surat, India.
J Clin Lab Anal. 2017 May;31(3). doi: 10.1002/jcla.22054. Epub 2016 Aug 26.
Hereditary hemochromatosis is a disorder of iron metabolism characterized by increased iron absorption.HFE gene mutations C282Y and H63D are responsible for the majority of hereditary hemochromatosis cases.
We tried to look at the effect of HFE mutations on the iron status. A total of 100 β thalassemia traits (BTT) with 100 normal individuals were screened for the C282Y and H63D mutations using PCR-RFLP. The serum ferritin levels were determined using ELISA kit.
We did not find the C282Y mutation in our study group. The allelic frequencies for H63D mutation did not differ significantly between β-thalassemia traits (8.5%) and normal controls (9%). ΒΤΤ with H63D genotype of H/D (143.16 ± 80.3 ng/ml) and D/D (504 ng/ml) showed higher ferritin levels as against H/H genotype (88.64 ± 92.43 ng/ml). The statistically significant difference was observed in the mean serum ferritin levels among the individuals showing H/H and D/D genotypes (P < 0.002) and H/D and D/D genotype (P < 0.01) in both the groups.
This suggests that iron load in BTT tends to aggravated with the co-inheritance of the H63D mutation. The mutant H63D gene showed the presence of haplotype 6 which is reported in the European population suggesting a common origin.
遗传性血色素沉着症是一种铁代谢紊乱疾病,其特征为铁吸收增加。HFE基因突变C282Y和H63D是大多数遗传性血色素沉着症病例的病因。
我们试图研究HFE突变对铁状态的影响。使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)对100例β地中海贫血性状(BTT)患者和100名正常个体进行C282Y和H63D突变筛查。使用酶联免疫吸附测定(ELISA)试剂盒测定血清铁蛋白水平。
在我们的研究组中未发现C282Y突变。β地中海贫血性状组(8.5%)和正常对照组(9%)的H63D突变等位基因频率无显著差异。与H/H基因型(88.64±92.43 ng/ml)相比,H/D基因型(143.16±80.3 ng/ml)和D/D基因型(504 ng/ml)的BTT患者铁蛋白水平更高。在两组中,H/H和D/D基因型个体(P<0.002)以及H/D和D/D基因型个体(P<0.01)的平均血清铁蛋白水平存在统计学显著差异。
这表明BTT患者的铁负荷在与H63D突变共同遗传时往往会加重。突变的H63D基因显示存在单倍型6,这在欧洲人群中已有报道,表明有共同起源。